Early Access — free while we kick the tires
EdgarHawk

Xiao Ting

Director

Director
1 filing analyzed · 1 company · Latest 2025-02-11

Companies

Company Buys Sells Direction
Zenas BioPharma, Inc. ZBIO 1 0 Net buying

Activity

February 2025
2025-02-11 Zenas BioPharma, Inc. ZBIO
high
Buy
10,000 shares
$77,600
Significance 6/10

Director Xiao Ting buys 10,000 shares of ZBIO at $7.76; stock -71.7% from 52-week high, company burning $38.6M quarterly net loss.

Xiao Ting purchased 10,000 shares at $7.76 on 2025-02-07, increasing holdings by 27.0% to 47,000 shares. The purchase occurs as the stock trades at $7.27, a -71.7% decline from the 52-week high of $25.68. Zenas BioPharma is a loss-making entity with a latest-quarter net loss of $-38.6M against revenue of $50.0M, indicating ongoing cash burn. The 30-day decline of -10.5% and the 90-day decline of -61.9% reflect sustained downward price pressure that preceded this buy, occurring in a context of significant operational losses and depressed valuation relative to recent highs.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access